Clinical indication of nasal surgery for the CPAP intolerance in obstructive sleep apnea with nasal obstruction.


Journal

Auris, nasus, larynx
ISSN: 1879-1476
Titre abrégé: Auris Nasus Larynx
Pays: Netherlands
ID NLM: 7708170

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 26 11 2019
revised: 11 06 2020
accepted: 19 06 2020
pubmed: 19 7 2020
medline: 31 8 2021
entrez: 19 7 2020
Statut: ppublish

Résumé

The role of isolated nasal surgery for obstructive sleep apnea (OSA) patients with nasal obstruction, especially for an intolerance for continuous positive airway pressure (CPAP), is unclear. The aim of this study was to assess the effects of surgery for OSA patients with symptomatic nasal obstruction and CPAP intolerance. Retrospectve comparative study.1037 OSA patients with apnea-hypopnea index (AHI) ≥ 20 were enrolled. Case-control study was performed between the male apnea patients undergoing nasal surgery: surgery group (n = 43) and the pair-matched apnea patients for age, sex, body mass index, and race: control group (n = 43). The surgery group suffering from nasal obstruction could not use continuous positive airway pressure, and the CPAP group free from nasal obstruction could use it successfully. In surgery group, surgery significantly decreased the nasal resistance and Epworth sleepiness scale scores without changing the AHI. Surgery significantly increased the nadir of oxygen saturation and shortened the apnea-hypopnea duration. Although all of the surgery group failed to use positive airway pressure preoperatively, the 40 patients of the 43 CPAP intolerance patients were able to use CPAP postoperatively. The resting three patients were cured OSA or changed the treatment to oral appliance(OA). For both groups, the cutoff nasal resistance for differentiating the failure of positive airway pressure and its success was 0.31 Pa/cm Isolated nasal surgery is effective for an intolerance of positive airway pressure in sleep apnea with nasal obstruction presumably by decreasing nasal resistance.

Identifiants

pubmed: 32680600
pii: S0385-8146(20)30148-6
doi: 10.1016/j.anl.2020.06.005
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1018-1022

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no financial conflicts of interest to declare.

Auteurs

Noboru Iwata (N)

Department of Otorhinolaryngology and Sleep Medicine, Second Hospital, Fujita Health University, Nagoya, Aichi, Japan.

Seiichi Nakata (S)

Department of Otorhinolaryngology and Sleep Medicine, Second Hospital, Fujita Health University, Nagoya, Aichi, Japan. Electronic address: seisay@fujita-hu.ac.jp.

Hiroya Inada (H)

Department of Otorhinolaryngology and Sleep Medicine, Second Hospital, Fujita Health University, Nagoya, Aichi, Japan.

Ayami Kimura (A)

Department of Otorhinolaryngology and Sleep Medicine, Second Hospital, Fujita Health University, Nagoya, Aichi, Japan.

Masatoshi Hirata (M)

Department of Clinical Laboratory, Second Hospital, Fujita Health University Nagoya, Aichi, Japan.

Fumihiko Yasuma (F)

Department of Medicine, National Hospital Organization Suzuka Hospital, Suzuka, Mie, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH